Selected research
Industry Research
Infection Prevention Surveillance Industry Research Report 2026
Market perspective
The global Infection Prevention Surveillance market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Infection Prevention Surveillance market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Infection Prevention Surveillance market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Infection Prevention Surveillance market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Infection Prevention Surveillance include BD, Wolters Kluwer, Gojo Industries Inc., International Business Machines Corporation, Premier Inc., Alpha Source Inc., RLDatixS. C., Baxter International Inc. and BioVigil and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Infection Prevention Surveillance market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Infection Prevention Surveillance.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Infection Prevention Surveillance Market by Company
BD
Wolters Kluwer
Gojo Industries Inc.
International Business Machines Corporation
Premier Inc.
Alpha Source Inc.
RLDatixS. C.
Baxter International Inc.
BioVigil
Johnson & Son
Infection Prevention Surveillance Segment by Type
Bloodstream Infections
Surgical Site Infections
Gastrointestinal Infections
Urinary Tract Infections (UTI)
Others
Infection Prevention Surveillance Segment by Application
Hospitals & Clinics
Ambulatory Surgical Centers
Academic Institutes
Others
Infection Prevention Surveillance Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infection Prevention Surveillance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Infection Prevention Surveillance and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infection Prevention Surveillance.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Infection Prevention Surveillance companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bloodstream Infections
- Surgical Site Infections
- Gastrointestinal Infections
- Urinary Tract Infections (UTI)
- Others
Applications
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Academic Institutes
- Others
Companies covered
- BD
- Wolters Kluwer
- Gojo Industries Inc.
- International Business Machines Corporation
- Premier Inc.
- Alpha Source Inc.
- RLDatixS. C.
- Baxter International Inc.
- BioVigil
- Johnson & Son
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Infection Prevention Surveillance by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Bloodstream Infections
- 2.2.3 Surgical Site Infections
- 2.2.4 Gastrointestinal Infections
- 2.2.5 Urinary Tract Infections (UTI)
- 2.2.6 Others
- 2.3 Infection Prevention Surveillance by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals & Clinics
- 2.3.3 Ambulatory Surgical Centers
- 2.3.4 Academic Institutes
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Infection Prevention Surveillance Breakdown Data by Type
- 3.1 Global Infection Prevention Surveillance Historic Market Size by Type (2021-2026)
- 3.2 Global Infection Prevention Surveillance Forecasted Market Size by Type (2027-2032)
4 Infection Prevention Surveillance Breakdown Data by Application
- 4.1 Global Infection Prevention Surveillance Historic Market Size by Application (2021-2026)
- 4.2 Global Infection Prevention Surveillance Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Infection Prevention Surveillance Market Perspective (2021-2032)
- 5.2 Global Infection Prevention Surveillance Growth Trends by Region
- 5.2.1 Global Infection Prevention Surveillance Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Infection Prevention Surveillance Historic Market Size by Region (2021-2026)
- 5.2.3 Infection Prevention Surveillance Forecasted Market Size by Region (2027-2032)
- 5.3 Infection Prevention Surveillance Market Dynamics
- 5.3.1 Infection Prevention Surveillance Industry Trends
- 5.3.2 Infection Prevention Surveillance Market Drivers
- 5.3.3 Infection Prevention Surveillance Market Challenges
- 5.3.4 Infection Prevention Surveillance Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Infection Prevention Surveillance Players by Revenue
- 6.1.1 Global Top Infection Prevention Surveillance Players by Revenue (2021-2026)
- 6.1.2 Global Infection Prevention Surveillance Revenue Market Share by Players (2021-2026)
- 6.2 Global Infection Prevention Surveillance Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Infection Prevention Surveillance Head Office and Area Served
- 6.4 Global Infection Prevention Surveillance Players, Product Type & Application
- 6.5 Global Infection Prevention Surveillance Manufacturers Established Date
- 6.6 Global Infection Prevention Surveillance Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Infection Prevention Surveillance Market Size (2021-2032)
- 7.2 North America Infection Prevention Surveillance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Infection Prevention Surveillance Market Size by Country (2021-2026)
- 7.4 North America Infection Prevention Surveillance Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Infection Prevention Surveillance Market Size (2021-2032)
- 8.2 Europe Infection Prevention Surveillance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Infection Prevention Surveillance Market Size by Country (2021-2026)
- 8.4 Europe Infection Prevention Surveillance Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Infection Prevention Surveillance Market Size (2021-2032)
- 9.2 Asia-Pacific Infection Prevention Surveillance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Infection Prevention Surveillance Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Infection Prevention Surveillance Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Infection Prevention Surveillance Market Size (2021-2032)
- 10.2 South America Infection Prevention Surveillance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Infection Prevention Surveillance Market Size by Country (2021-2026)
- 10.4 South America Infection Prevention Surveillance Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Infection Prevention Surveillance Market Size (2021-2032)
- 11.2 Middle East & Africa Infection Prevention Surveillance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Infection Prevention Surveillance Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Infection Prevention Surveillance Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BD
- 12.1.1 BD Company Information
- 12.1.2 BD Business Overview
- 12.1.3 BD Revenue in Infection Prevention Surveillance Business (2021-2026)
- 12.1.4 BD Infection Prevention Surveillance Product Portfolio
- 12.1.5 BD Recent Developments
- 12.2 Wolters Kluwer
- 12.2.1 Wolters Kluwer Company Information
- 12.2.2 Wolters Kluwer Business Overview
- 12.2.3 Wolters Kluwer Revenue in Infection Prevention Surveillance Business (2021-2026)
- 12.2.4 Wolters Kluwer Infection Prevention Surveillance Product Portfolio
- 12.2.5 Wolters Kluwer Recent Developments
- 12.3 Gojo Industries Inc.
- 12.3.1 Gojo Industries Inc. Company Information
- 12.3.2 Gojo Industries Inc. Business Overview
- 12.3.3 Gojo Industries Inc. Revenue in Infection Prevention Surveillance Business (2021-2026)
- 12.3.4 Gojo Industries Inc. Infection Prevention Surveillance Product Portfolio
- 12.3.5 Gojo Industries Inc. Recent Developments
- 12.4 International Business Machines Corporation
- 12.4.1 International Business Machines Corporation Company Information
- 12.4.2 International Business Machines Corporation Business Overview
- 12.4.3 International Business Machines Corporation Revenue in Infection Prevention Surveillance Business (2021-2026)
- 12.4.4 International Business Machines Corporation Infection Prevention Surveillance Product Portfolio
- 12.4.5 International Business Machines Corporation Recent Developments
- 12.5 Premier Inc.
- 12.5.1 Premier Inc. Company Information
- 12.5.2 Premier Inc. Business Overview
- 12.5.3 Premier Inc. Revenue in Infection Prevention Surveillance Business (2021-2026)
- 12.5.4 Premier Inc. Infection Prevention Surveillance Product Portfolio
- 12.5.5 Premier Inc. Recent Developments
- 12.6 Alpha Source Inc.
- 12.6.1 Alpha Source Inc. Company Information
- 12.6.2 Alpha Source Inc. Business Overview
- 12.6.3 Alpha Source Inc. Revenue in Infection Prevention Surveillance Business (2021-2026)
- 12.6.4 Alpha Source Inc. Infection Prevention Surveillance Product Portfolio
- 12.6.5 Alpha Source Inc. Recent Developments
- 12.7 RLDatixS. C.
- 12.7.1 RLDatixS. C. Company Information
- 12.7.2 RLDatixS. C. Business Overview
- 12.7.3 RLDatixS. C. Revenue in Infection Prevention Surveillance Business (2021-2026)
- 12.7.4 RLDatixS. C. Infection Prevention Surveillance Product Portfolio
- 12.7.5 RLDatixS. C. Recent Developments
- 12.8 Baxter International Inc.
- 12.8.1 Baxter International Inc. Company Information
- 12.8.2 Baxter International Inc. Business Overview
- 12.8.3 Baxter International Inc. Revenue in Infection Prevention Surveillance Business (2021-2026)
- 12.8.4 Baxter International Inc. Infection Prevention Surveillance Product Portfolio
- 12.8.5 Baxter International Inc. Recent Developments
- 12.9 BioVigil
- 12.9.1 BioVigil Company Information
- 12.9.2 BioVigil Business Overview
- 12.9.3 BioVigil Revenue in Infection Prevention Surveillance Business (2021-2026)
- 12.9.4 BioVigil Infection Prevention Surveillance Product Portfolio
- 12.9.5 BioVigil Recent Developments
- 12.10 Johnson & Son
- 12.10.1 Johnson & Son Company Information
- 12.10.2 Johnson & Son Business Overview
- 12.10.3 Johnson & Son Revenue in Infection Prevention Surveillance Business (2021-2026)
- 12.10.4 Johnson & Son Infection Prevention Surveillance Product Portfolio
- 12.10.5 Johnson & Son Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst